Literature DB >> 8352566

The reversal of multidrug resistance in cancer (review).

J A Kellen1.   

Abstract

A brief review of the "state of the art" (1992) knowledge concerning various strategies and tactics to overcome multidrug resistance is presented. Multidrug resistance remains the main obstacle to long-term successful cancer chemotherapy; its prevention or elimination is probably one of the most promising avenues in cancer research.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8352566

Source DB:  PubMed          Journal:  Anticancer Res        ISSN： 0250-7005            Impact factor:   2.480


  7 in total

1.  Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.

Authors:  C E Soma; C Dubernet; G Barratt; F Nemati; M Appel; S Benita; P Couvreur
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

2.  Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs.

Authors:  W Walther; U Stein
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 3.  Molecular biology of leukemia for the clinician.

Authors:  E Paietta
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

4.  Cytokine-mediated reversal of multidrug resistance.

Authors:  U Stein; W Walther
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

5.  Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.

Authors:  A C de Verdière; C Dubernet; F Némati; E Soma; M Appel; J Ferté; S Bernard; F Puisieux; P Couvreur
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance.

Authors:  U Stein; W Walther; R H Shoemaker
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

7.  Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres.

Authors:  Yu-Te Liao; Chia-Hung Liu; Jiashing Yu; Kevin C-W Wu
Journal:  Int J Nanomedicine       Date:  2014-06-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.